Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT

✍ Scribed by R. Swords; P. J. Hayden; K. Molloy; M. Lawlor; P. V. Browne; P. T. Murphy

• Book ID: 114792724
• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 65 KB
• Volume: 73
• Category: Article
• ISSN: 0902-4441
• DOI: 10.1111/j.1600-0609.2004.00321.x